BCR/ABL1-Like Acute Lymphoblastic Leukemia: From Diagnostic Approaches to Molecularly Targeted Therapy
Acta Haematologica · 2022 · 145 (2) · 122-131
DOI: 10.1159/000519782 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Acta Haematologica, online erschienen am 24.11.2021. Verfasst von Anna Płotka und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznań, Poland. Hauptthemen laut MEDLINE: Molecular Targeted Therapy, Precursor Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 63 Literaturangaben.
Abstract (Originalsprache)
Background: BCR/ABL1-like acute lymphoblastic leukemia is a newly recognized high-risk subtype of ALL, characterized by the presence of genetic alterations activating kinase and cytokine receptor signaling. This subtype is associated with inferior outcomes, compared to other B-cell precursor ALL. Summary: The recognition of BCR/ABL1-like ALL is challenging due to the complexity of underlying genetic alterations. Rearrangements of CRLF2 are the most frequent alteration in BCR/ABL1-like ALL and can be identified by flow cytometry. The identification of BCR/ABL1-like ALL can be achieved with stepwise algorithms or broad-based testing. The main goal of the diagnostic analysis is to detect the underlying genetic alterations, which are critical for the diagnosis and targeted therapy. Key Messages: The aim of the manuscript is to review the available data on BCR/ABL1-like ALL characteristics, diagnostic algorithms, and novel, molecularly targeted therapeutic options.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznań, Poland.
Zitieren
APA
Płotka, A., & Lewandowski, K. (2022). BCR/ABL1-Like Acute Lymphoblastic Leukemia: From Diagnostic Approaches to Molecularly Targeted Therapy. Acta Haematologica, 145(2), 122-131. https://doi.org/10.1159/000519782
Vancouver
Płotka A, Lewandowski K. BCR/ABL1-Like Acute Lymphoblastic Leukemia: From Diagnostic Approaches to Molecularly Targeted Therapy. Acta Haematologica. 2022;145(2):122-131. doi:10.1159/000519782
BibTeX
@article{Potka2022,
author = {Płotka, Anna and Lewandowski, Krzysztof},
title = {BCR/ABL1-Like Acute Lymphoblastic Leukemia: From Diagnostic Approaches to Molecularly Targeted Therapy},
journal = {Acta Haematologica},
year = {2022},
volume = {145},
number = {2},
pages = {122--131},
doi = {10.1159/000519782}
}
EUVIMED